Paul Meyvisch

3 ta ish

Janssen (Belgium)

1. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

   Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch +13

   MaqolaOAOchiq kirish20144 iqtibos

   ABIABI:AkademIndex/2026.other.034203

2. Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

   Andreas H. Diacon, Peter R. Donald, Alexander S. Pym +11

   MaqolaOAOchiq kirish20123 iqtibos

   ABIABI:AkademIndex/2026.other.185768

3. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

   Alexander S. Pym, Andreas H. Diacon, Shenjie Tang +13

   MaqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.034200